Wealthcare Advisory Partners’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,966
| Closed | -$57K | – | 1733 |
|
|
2021
Q1 | $57K | Buy |
+4,966
| New | +$57K | ﹤0.01% | 839 |
|
|
2020
Q2 | – | Sell |
-1,242
| Closed | -$11K | – | 1242 |
|
|
2020
Q1 | $11K | Buy |
1,242
+1,125
| +962% | +$9.96K | ﹤0.01% | 908 |
|
|
2019
Q4 | $1K | Sell |
117
-184
| -61% | -$1.57K | ﹤0.01% | 1345 |
|
|
2019
Q3 | $2K | Sell |
301
-50
| -14% | -$332 | ﹤0.01% | 1241 |
|
|
2019
Q2 | $3K | Sell |
351
-50
| -12% | -$427 | ﹤0.01% | 1156 |
|
|
2019
Q1 | $6K | Hold |
401
| – | – | ﹤0.01% | 935 |
|
|
2018
Q4 | $6K | Buy |
401
+50
| +14% | +$748 | ﹤0.01% | 903 |
|
|
2018
Q3 | $8K | Hold |
351
| – | – | ﹤0.01% | 914 |
|
|
2018
Q2 | $9K | Sell |
351
-4,618
| -93% | -$118K | ﹤0.01% | 875 |
|
|
2018
Q1 | $85K | Buy |
4,969
+50
| +1% | +$855 | 0.02% | 309 |
|
|
2017
Q4 | $93K | Buy |
4,919
+3,401
| +224% | +$64.3K | 0.02% | 271 |
|
|
2017
Q3 | $27K | Buy |
+1,518
| New | +$27K | 0.01% | 387 |
|